Cost-effectiveness analyses of natalizumab (Tysabri) compared with other disease-modifying therapies for people with highly active relapsing-remitting multiple sclerosis in the UK.
| Image |  |
|---|---|
| Description | scientific article published on January 2008 |
| Author/s |
author: Gavin Giovannoni |
| Publication date | January 1, 2008 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |